Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 7 studies | 24% ± 11% | |
| retinal cone cell | 6 studies | 31% ± 7% | |
| retinal rod cell | 5 studies | 21% ± 2% | |
| epithelial cell | 4 studies | 30% ± 4% | |
| GABAergic neuron | 3 studies | 21% ± 5% | |
| glutamatergic neuron | 3 studies | 34% ± 4% | |
| hepatocyte | 3 studies | 41% ± 19% | |
| astrocyte | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2253.26 | 245 / 245 | 99% | 33.38 | 499 / 502 |
| thymus | 100% | 3489.02 | 653 / 653 | 99% | 43.74 | 597 / 605 |
| brain | 96% | 677.06 | 2547 / 2642 | 99% | 22.44 | 701 / 705 |
| bladder | 100% | 2563.52 | 21 / 21 | 94% | 32.74 | 473 / 504 |
| kidney | 100% | 1081.88 | 89 / 89 | 93% | 13.67 | 841 / 901 |
| breast | 100% | 1081.74 | 457 / 459 | 92% | 24.83 | 1030 / 1118 |
| adrenal gland | 100% | 1436.27 | 258 / 258 | 91% | 13.94 | 209 / 230 |
| liver | 98% | 1133.56 | 221 / 226 | 93% | 19.32 | 377 / 406 |
| uterus | 99% | 1031.64 | 169 / 170 | 90% | 18.33 | 411 / 459 |
| esophagus | 100% | 1516.00 | 1443 / 1445 | 89% | 13.76 | 163 / 183 |
| pancreas | 89% | 401.46 | 293 / 328 | 96% | 13.04 | 171 / 178 |
| skin | 100% | 1766.61 | 1809 / 1809 | 84% | 10.48 | 398 / 472 |
| lung | 95% | 717.39 | 551 / 578 | 87% | 12.78 | 1006 / 1155 |
| intestine | 100% | 1315.45 | 966 / 966 | 80% | 8.05 | 424 / 527 |
| stomach | 98% | 626.49 | 351 / 359 | 73% | 7.40 | 209 / 286 |
| ovary | 100% | 1075.33 | 180 / 180 | 55% | 4.52 | 236 / 430 |
| spleen | 100% | 716.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 36.41 | 1 / 1 |
| blood vessel | 100% | 1158.23 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 761.26 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 738.21 | 794 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 23.51 | 43 / 45 |
| heart | 87% | 480.55 | 753 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 5.18 | 18 / 29 |
| eye | 0% | 0 | 0 / 0 | 31% | 2.52 | 25 / 80 |
| peripheral blood | 28% | 223.68 | 262 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015908 | Biological process | fatty acid transport |
| GO_0006635 | Biological process | fatty acid beta-oxidation |
| GO_0006091 | Biological process | generation of precursor metabolites and energy |
| GO_0051791 | Biological process | medium-chain fatty acid metabolic process |
| GO_0009437 | Biological process | carnitine metabolic process |
| GO_0006631 | Biological process | fatty acid metabolic process |
| GO_0015936 | Biological process | coenzyme A metabolic process |
| GO_0033540 | Biological process | fatty acid beta-oxidation using acyl-CoA oxidase |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005829 | Cellular component | cytosol |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005782 | Cellular component | peroxisomal matrix |
| GO_0008458 | Molecular function | carnitine O-octanoyltransferase activity |
| Gene name | CROT |
| Protein name | Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137) Carnitine O-octanoyltransferase |
| Synonyms | COT |
| Description | FUNCTION: Beta-oxidation of fatty acids. The highest activity concerns the C6 to C10 chain length substrate. Converts the end product of pristanic acid beta oxidation, 4,8-dimethylnonanoyl-CoA, to its corresponding carnitine ester. . |
| Accessions | Q9UKG9 ENST00000442291.1 ENST00000331536.8 [Q9UKG9-1] ENST00000412227.6 [Q9UKG9-2] C9J3D7 ENST00000419147.6 [Q9UKG9-3] |
